DIMENSIONAL FUND ADVISORS LP
Position in HRMY — Harmony Biosciences Holdings, Inc.
CIK 354204
AUSTIN, TX
Position in HRMY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$87,150,537
+$28,987,495 QoQ
Shares Held
2,393,588
+15.3% QoQ
Ownership
4.11%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#5
of 328 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 92%
Shared 5%
None 2%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. HRMY ranks #19 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in HRMY
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $87,150,537 | 2,393,588 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $58,163,042 | 2,076,510 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $68,505,765 | 1,830,726 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $46,619,971 | 1,691,581 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $49,996,759 | 1,582,176 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $40,650,910 | 1,224,794 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $41,740,326 | 1,213,029 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $42,101,560 | 1,052,539 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $28,866,201 | 956,785 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $28,361,263 | 844,588 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $23,781,454 | 736,268 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $25,706,227 | 784,444 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $25,778,468 | 732,551 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $27,165,680 | 832,027 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $31,980,258 | 580,404 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $24,925,081 | 562,770 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $22,321,442 | 457,688 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $16,835,429 | 346,052 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $8,319,959 | 195,121 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $1,395,058 | 36,396 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||